Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Women Benefit Less From Clot-Busting Stroke Drug


Related Encyclopedia
 border=
Acoustic Neurinoma
Alzheimer's Disease
Amenorrhea
Amniocentesis
More...

Related Healthscout Videos
 border=
Brain Surgery with Water?
Preventing Breast Cancer
Tracking Breast Cancer Treatment
Howard: The Helping Hand for Stroke Survivors
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Angioplasty
Breast Reduction
Breast Self-Exam Video
More...

Related Drug Information
 border=
Accupril
Actonel
Adderal XR
Altace
More...

Related News Articles
 border=
Pelvic Floor Disorders Affect 1 in 3 Women
Common Rheumatoid Arthritis Drug Won't Raise Blood Cancer Risk
Chemo Break Benefits Some Men With Prostate Cancer
Double Lung Transplant Better for Younger COPD Patients
More...


Page:  << Prev | 1 | 2

But Elkind added that, "at this point in time, it is premature to treat women differently [than men] after a stroke. We recommend that women as well as men get to a hospital as quickly as possible and be treated as aggressively, including tPA."

There have been indications that postmenopausal women have higher levels than men of a substance that inhibits tPA activity, Abrams said. "A lot more work would have to be done to prove it, but it is an intriguing thought. But there is conflicting evidence and reasons to believe there are caveats in taking this too far."

The results should also be interpreted cautiously, noted Dr. Edgar J. Kenton III, chair of the American Academy of Neurology's practice committee. "This is the only large trial of the response to tPA in women," he said. "We need more trials proving the point one way or another."

Text Continues Below



"I don't want this study interpreted to say that women should not get tPA," Kenton stressed. "There are small studies suggesting that with ultra-early treatment -- within one hour -- they do better than men. We need more women in more trials to look at these factors."

Kenton also noted the unusually high percentage of patients in the study who received tPA therapy within the three-hour post-stroke limit recommended by experts.

"Twenty-four percent got tPA within three hours," Kenton noted. "The national average is 5 or 6 percent." The measures used in this trial to get tPA delivered to patients early can and should be applied to everyday practice, he said.

More information

Find out more about tPA at the American Heart Association.

Page:  << Prev | 1 | 2

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 3/13/2007

Related Links
 border=
From Healthscout's partner site on cholesterol, CholesterolNetwork.com
VIDEO: Open Arteries with a Cancer Drug
ONLINE TEST: Take our Home Body Fat Test!
QUIZ: Recommended Daily Calories and Fat





New Features

New ADHD Site!

SOURCES: Gary Abrams, M.D., associate professor, neurology, University of California, San Francisco, director, Neurorehabilitation Clinic, UCSF Medical Center, and spokesman, American Academy of Neurology; Mitchell S. V. Elkind, M.D., associate professor of neurology, Columbia University, New York City; Edgar J. Kenton III, M.D., chair, American Academy of Neurology practice committee; March 13, 2007, Neurology


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map